These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16751199)

  • 1. Antimicrobial and toxicological profile of the new biocide Akacid plus.
    Buxbaum A; Kratzer C; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 2006 Jul; 58(1):193-7. PubMed ID: 16751199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antimicrobial activity of the novel polymeric guanidine Akacid plus.
    Kratzer C; Tobudic S; Graninger W; Buxbaum A; Georgopoulos A
    J Hosp Infect; 2006 Jul; 63(3):316-22. PubMed ID: 16698119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of AKACID plus as a room disinfectant in the hospital setting.
    Kratzer C; Tobudic S; Assadian O; Buxbaum A; Graninger W; Georgopoulos A
    Appl Environ Microbiol; 2006 Jun; 72(6):3826-31. PubMed ID: 16751486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
    Kratzer C; Tobudic S; Schmoll M; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 2006 Nov; 58(5):1058-61. PubMed ID: 16987867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic compounds with activity against multidrug-resistant bacteria: interest of a new compound compared with two older antiseptics, hexamidine and chlorhexidine.
    Grare M; Dibama HM; Lafosse S; Ribon A; Mourer M; Regnouf-de-Vains JB; Finance C; Duval RE
    Clin Microbiol Infect; 2010 May; 16(5):432-8. PubMed ID: 19456831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
    Jones RN; Huynh HK; Biedenbach DJ; Fritsche TR; Sader HS
    J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyhexamethylene guanidine hydrochloride shows bactericidal advantages over chlorhexidine digluconate against ESKAPE bacteria.
    Zhou Z; Wei D; Lu Y
    Biotechnol Appl Biochem; 2015; 62(2):268-74. PubMed ID: 24888899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    J Antimicrob Chemother; 2008 May; 61(5):1092-8. PubMed ID: 18310135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural evidences of growth inhibitory effects of a novel biocide, Akacid(plus), on an aflatoxigenic Aspergillus parasiticus.
    Razzaghi-Abyaneh M; Shams-Ghahfarokhi M; Kawachi M; Eslamifar A; Schmidt OJ; Schmidt A; Allameh A; Yoshinari T
    Toxicon; 2006 Dec; 48(8):1075-82. PubMed ID: 17049365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
    Pillar CM; Aranza MK; Shah D; Sahm DF
    J Antimicrob Chemother; 2008 Mar; 61(3):595-602. PubMed ID: 18218646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of antibiotic and antimicrobial biocide susceptibility data in clinical isolates of methicillin-sensitive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa between 1989 and 2000.
    Lambert RJ
    J Appl Microbiol; 2004; 97(4):699-711. PubMed ID: 15357719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 May; 61(1):86-95. PubMed ID: 18385000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
    Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
    J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo activity of a novel polymeric guanidine in experimental skin infection with methicillin-resistant Staphylococcus aureus.
    Kratzer C; Tobudic S; Macfelda K; Graninger W; Georgopoulos A
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3437-9. PubMed ID: 17620381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Causative agents of intravenous catheter-related infections and their antibiotic susceptibilities].
    Aktaş E; Sarı EN; Seremet Keskin A; Pişkin N; Külah C; Cömert F
    Mikrobiyol Bul; 2011 Jan; 45(1):86-92. PubMed ID: 21341163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates.
    López-Brea M; Alarcón T; Domingo D; Díaz-Regañón J
    J Antimicrob Chemother; 2008 Jan; 61(1):139-42. PubMed ID: 17965421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.